HLAs: Key regulators of T‐cell‐mediated drug hypersensitivity

Publisher： John Wiley & Sons Inc

E-ISSN： 2059-2310|91|1|3-16

ISSN： 2059-2302

Source： HLA, Vol.91, Iss.1, 2018-01, pp. : 3-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dasatinib-Induced T-Cell-Mediated Colitis: A Case Report and Review of the Literature

By  

Acta Haematologica, Vol. 136, Iss. 4, 2016-09 ,pp. : 219-228

Karger

Access to resources Recommend Favorite

T Cell Receptor Mimic Peptidesand Their Potential Application in T-Cell-Mediated Diseas e

By  

International Archives of Allergy and Immunology, Vol. 123, Iss. 4, 2000-12 ,pp. : 275-281

Karger

Access to resources Recommend Favorite

Treatment with the TLR7 agonist R848 induces regulatory T‐cell‐mediated suppression of established asthma symptoms

By  

EUROPEAN JOURNAL OF IMMUNOLOGY, Vol. 41, Iss. 7, 2011-07 ,pp. : 1992-1999

John Wiley & Sons Inc

Access to resources Recommend Favorite

TCR down‐regulation boosts T‐cell‐mediated cytotoxicity and protection against poxvirus infections

By  

EUROPEAN JOURNAL OF IMMUNOLOGY, Vol. 41, Iss. 7, 2011-07 ,pp. : 1948-1957

John Wiley & Sons Inc

Access to resources Recommend Favorite

β-Estradiol Suppresses T Cell-Mediated Delayed-Type Hypersensitivity through Suppression of Antigen-Presenting Cell Function and Th1 Induction

By  

International Archives of Allergy and Immunology, Vol. 121, Iss. 2, 2009-07 ,pp. : 161-169

Karger

Access to resources Recommend Favorite